Effects of Metformin on PKC-β expression in renal tissue of type 2 diabetic rats

余丹,叶山东,李业琼,胡闻
DOI: https://doi.org/10.3969/j.issn.1006-6187.2017.10.010
2017-01-01
Abstract:Objective To investigate the effects of Metformin(MET) on protein kinase C-β(PKC-β) mRNA and protein expression in renal tissue of SD rats with type 2 diabetes mellitus(T2DM),and to explore the protective mechanism of Metformin indiabetic kidney disease(DKD).Methods Type 2 diabetic rat model was created by high-fat diets and intraperitoneal injection of low-dose strept ozotocin (STZ).A total of 37 rats were selected in this study and divided into normal control group(NC group,n=10] and T2DM model group(DM,n=27).Then DM group was randomly divided into Metformin intervention group(MET,n=8),Glibenclamide intervention group(GLY,n=9),and diabetic control group (T2DM,n=10).HbA1 c,fasting blood glucose(FBG),urea nitrogen(BUN),urinary albumin,and basal membrane thickness(GBMT) were detected after 8 weeks.The expressions of PKC-β protein and mRNA in renal tissue were detected as well.Results After 8 weeks,FBG[(4.45 ± 1.07) vs (15.6 ± 1.56) mmol/L) and HbA1c[(4.13±0.89)% vs (12.41±0.61) %)increased in T2DM group than in NC group (P<0.05),but PKC-βIoD[(22.24±2.39) vs(42.00±4.90)] and PKC-β mRNA[(1.00±0.04) vs (2.16± 0.13)] increased in T2DM group than in NC group(P<0.05).PKC-βIoD[(42.00±4.90) vs (27.32± 1.71)] and PKC-RnRNA[(2.16±0.13) vs (1.11±0.02)] decreased in MET group than in T2DM group (P<0.05).PKC-βIOD [(30.73 ± 1.95) vs (27.32 ± 1.71)]and PKC-βmRNA [(1.75 ± 0.02) vs (1.11 ± 0.02)] decreased in MET group than in GLY group(P<0.05).Conclusion Metformin can decrease the over-expression of PKC-β in renal tissue of diabetic rats,which may be related to its renal protective mechanism.
What problem does this paper attempt to address?